Jeffrey Brewer, CEO, founded two successful technology start-ups, CitySearch and Overture / GoTo.com, that later became publicly traded companies where he served as CEO and raised over $90M in private investment and over $350M in IPO and follow-on equity offerings. As a volunteer, donor, and International Board Member of the Juvenile Diabetes Research Foundation (JDRF), he launched the JDRF Artificial Pancreas Project in 2005, and later served as CEO of JDRF. In the role of CEO, Jeffrey forged financial partnerships with industry to drive research and development of insulin delivery and glucose monitoring. He further spearheaded US regulatory reform in the area of automated insulin delivery, and elevated the organization’s strategic priorities to include health care policy, reimbursement, and access to technology for people with T1D. Jeffrey co-founded Bigfoot Biomedical in late 2014, and the company is fast-tracking towards achieving its mission of providing all people with T1D an accessible, automated, connected solution designed to improve health and economic outcomes, make managing and living with T1D easier and safer, and reduce the support needed from the healthcare system.